Back    Zoom +    Zoom -
<Results>HENGRUI PHARMA Sees 21.78% YoY Growth in 1Q NP Attributable to Shareholders
Recommend
10
Positive
11
Negative
3
aacat by AASTOCKS
Open a new trading account to get NVDA share!
HENGRUI PHARMA (01276.HK) announced that its operating revenue for 1Q26 rose by 12.98% YoY to RMB8.141 billion, while net profit attributable to its shareholders increased by 21.78% YoY to RMB2.282 billion, with basic EPS of RMB0.34.



Auto-translated by AI
View Original Text

AASTOCKS Financial News
  • Remark
  • (1) HK Indices are real time
Home|RT Quote|Market|News|Indices
Feedback|Disclaimer
View: Mobile|Desktop
Lang: 繁|简|EN
Back To Top
Contact Us
Email: support@aastocks.com